We have previously generated a transgenic mouse model by overexpressing Ifitm5 cDNA with the novel start codon, corresponding to the recurrent human OI type V mutation, under the control of the Col1a1 2.3 kb promoter (19). This evidence concerns the gene IFITM5 and osteogenesis imperfecta type 5.